Glenmark gets USFDA nod for nasal spray to treat seasonal allergic rhinitis

Glenmark Pharmaceuticals on Friday said its subsidiary has received approval from the US health regulator to market Ryaltris, a nasal spray for the treatment of seasonal allergic rhinitis.
Category: News